Oliver Distler is Professor at the University of Zurich and Chairman of the Department of Rheumatology, University Hospital Zurich and the Balgrist University Hospital in Zurich, Switzerland. Since 2018, he is Head of the Business Division, Traumatology-Dermatology-Rheumatology-Plastic Surgery and Emergency Medicine (TDR), at the University Hospital Zurich in Switzerland and Board Member at the Faculty of Medicine at the University of Zurich.
Next to his clinical work at the outpatient and inpatient clinic in the field of Rheumatology, he is regularly involved in teaching activities and speaker at international conferences and further educations. He is also involved in the organization of international major scientific meetings and national further education. In addition, he is Co-Founder of multiple international networks and training programs, e.g. EUSTAR (European Scleroderma Trials and Research Group), World Scleroderma Congress, JSRD (Journal of scleroderma and related diseases), Educational Masterclass series on SSc-ILD.
With over 250 original research publications, he is also heading the Center of Experimental Rheumatology of the University of Zurich and supervisor of various graduate students and postdoctoral fellows. He is ad hoc reviewer for all major Rheumatology journals (including the leading journals ARD, A&R, Lancet Rheumatology), for journals from General Internal Medicine and other fields (including NEJM and Lancet), different national and international funding agencies (including e.g. DFG), different foundations (including Pfizer Foundation, Hartmann Müller Foundation) and frequent abstract reviewer for the large international congresses in Rheumatology (including EULAR, ACR, Scleroderma World Congress). He is also editorial board member of Lancet Rheumatology and Annals of the Rheumatic Diseases (ARD).